KCL Capital’s Axcella Health Inc. Common Stock AXLA Stock Holding History

KCL Capital’s Portfolio AXLA Stock Details AXLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-400	Closed	-$93K	–	58
2019 Q2	$93K	Buy	+400	New	+$127K	0.01%	43

Other funds holding AXLA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIC

Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

KCL Capital's AXLA Position: Q3 2019 in Review

KCL Capital sold out of Axcella Health Inc. Common Stock (AXLA) in Q3 2019, closing a stake of 400 shares — an estimated $93K sold.

KCL Capital first reported a position in AXLA in Q2 2019 and held it in 1 quarter. The position peaked at $93K in Q2 2019. 29 funds tracked by Wall St. Rank hold AXLA as of Q3 2019.

KCL Capital reported no remaining Axcella Health Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
KCL Capital sold 400 Axcella Health Inc. Common Stock shares in Q3 2019, an estimated $93K.
KCL Capital first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 1 quarter.
KCL Capital's Axcella Health Inc. Common Stock position peaked at $93K in Q2 2019.
29 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q3 2019.

Based on KCL Capital's 13F filing for Q3 2019, filed 14 Nov 2019.